The European Medicines Agency (EMA) is seeking to sign a contract for access to and use of a set of individual patient-level databases drawn from the population receiving primary care, specialist care and/or hospital care in EU/EEA countries. The Agency must have direct electronic access to data in-house or remotely (from EMA premises), immediately, and on its own initiative.

The set of individual patient-level databases may include electronic health care or claims databases and longitudinal drug prescription, dispensing or other drug utilisation databases.

The European Medicines Agency (EMA) is seeking to sign a contract for access to and use of a set of individual patient-level databases drawn from the population receiving primary care, specialist care and/or hospital care in EU/EEA countries. The Agency must have direct electronic access to data in-house or remotely (from EMA premises), immediately, and on its own initiative.

The set of individual patient-level databases may include electronic health care or claims databases and longitudinal drug prescription, dispensing or other drug utilisation databases.

The Agency wishes to conclude one contract covering:

1) ‘baseline services’ (fixed component), and

2) ‘additional services’ (i.e. access to further databases) as and when required.